Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesh Raghu

Showing results (21-30 of 339) with videos related to

Pageof 34
Sort By:
The European Respiratory Journal|December 8, 2018
Palliative care for patients with pulmonary fibrosis: symptom relief is essentialKathleen Lindell, Ganesh Raghu
Lung India : Official Organ of Indian Chest Society|November 29, 2016
Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registryGanesh Raghu, Sanjeev Mehta
The Lancet. Respiratory Medicine|December 15, 2022
Licensure laws and other barriers to telemedicine and telehealth: an urgent need for reformGanesh Raghu, Ateev Mehrotra
Clinics in Chest Medicine|November 27, 2004
Idiopathic pulmonary fibrosis: current trends in managementGanesh Raghu, Jacqueline Chang
European Respiratory Review : an Official Journal of the European Respiratory Society|June 25, 2021
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and managementSuha Kadura, Ganesh Raghu
Respirology (Carlton, Vic.)|August 23, 2022
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?Ryoko Egashira, Ganesh Raghu
The European Respiratory Journal|May 5, 2023
Acute exacerbation of fibrotic interstitial lung disease beyond idiopathic pulmonary fibrosis: time to interveneRyoko Egashira, Ganesh Raghu
European Respiratory Review : an Official Journal of the European Respiratory Society|November 9, 2021
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a reviewSuha Kadura, Ganesh Raghu
American Journal of Respiratory and Critical Care Medicine|January 31, 2015
Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questionsGanesh Raghu, Moisés Selman
American Journal of Respiratory and Critical Care Medicine|April 26, 2016
Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic DrugsYohannes T Ghebre, Ganesh Raghu
Pageof 34

Showing results (21-30 of 339) with videos related to

Sort By:
Pageof 34
The European Respiratory Journal|December 8, 2018
Palliative care for patients with pulmonary fibrosis: symptom relief is essentialKathleen Lindell, Ganesh Raghu
Lung India : Official Organ of Indian Chest Society|November 29, 2016
Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registryGanesh Raghu, Sanjeev Mehta
The Lancet. Respiratory Medicine|December 15, 2022
Licensure laws and other barriers to telemedicine and telehealth: an urgent need for reformGanesh Raghu, Ateev Mehrotra
Clinics in Chest Medicine|November 27, 2004
Idiopathic pulmonary fibrosis: current trends in managementGanesh Raghu, Jacqueline Chang
European Respiratory Review : an Official Journal of the European Respiratory Society|June 25, 2021
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and managementSuha Kadura, Ganesh Raghu
Respirology (Carlton, Vic.)|August 23, 2022
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?Ryoko Egashira, Ganesh Raghu
The European Respiratory Journal|May 5, 2023
Acute exacerbation of fibrotic interstitial lung disease beyond idiopathic pulmonary fibrosis: time to interveneRyoko Egashira, Ganesh Raghu
European Respiratory Review : an Official Journal of the European Respiratory Society|November 9, 2021
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a reviewSuha Kadura, Ganesh Raghu
American Journal of Respiratory and Critical Care Medicine|January 31, 2015
Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questionsGanesh Raghu, Moisés Selman
American Journal of Respiratory and Critical Care Medicine|April 26, 2016
Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic DrugsYohannes T Ghebre, Ganesh Raghu
Pageof 34